In March 2025, the company declared new strategies for a direct-to-client offering of its Wegovy weight loss drug. The company recognized a brand new pharmacy, referred to as NovoCare, which would charge buyers $499 per 30 days for use of the drug, fewer than half the cost of the drug through other pharmaceutical distribution networks.[53]Rybelsus … Read More